Physician Assistant Program year 2023 Reported 2021–2023 Source: CMS Open Payments, 2026 publication

Michael McCoy

Physician Assistant Charlotte, NC Physician Assistant

NPI 1881257277 CMS profile 10634376

200 Hawthorne Ln, Charlotte, NC 28204

Open in the dashboard

General payments

$3,441

182 records reported · program years 2021–2023

Research payments

$0

Paid to them · None reported · program years 2021–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Michael McCoy of Charlotte, NC is reported in the CMS Open Payments database as having received $3,441 across 182 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $934 43
2022 General $1,321 69
2021 General $1,186 70

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael McCoy
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Michael McCoy were reported at $0. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Michael McCoy Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,186 $132 $37–$438 $132
2022 $1,321 $155 $48–$522 $149
2023 $934 $167 $52–$557 $160
2024 $0 $178 $55–$600 $164
2025 $0 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2023
  1. Novartis Pharmaceuticals Corporation $503 22 payments
  2. AbbVie, Inc. $482 26 payments
  3. Janssen Pharmaceuticals, Inc $407 22 payments
  4. Gilead Sciences, Inc. $246 12 payments
  5. Pfizer Inc. $244 16 payments
  6. Boehringer Ingelheim Pharmaceuticals, Inc. $240 10 payments
  7. Paratek Pharmaceuticals, Inc. $221 15 payments
  8. AstraZeneca Pharmaceuticals LP $174 10 payments
  9. Alnylam Pharmaceuticals Inc. $162 7 payments
  10. Alexion Pharmaceuticals, Inc. $113 6 payments
  11. Other $649 36 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2023
  1. Food and Beverage $3,441 182 payments
Products named General payments · program years 2021–2023
  1. XARELTO $407 22 payments
  2. ENTRESTO $400 18 payments
  3. ELIQUIS $244 16 payments
  4. JARDIANCE $240 10 payments
  5. DALVANCE $234 15 payments
  6. TEFLARO $229 10 payments
  7. NUZYRA $221 15 payments
  8. GIVLAARI $162 7 payments
  9. SPIRIVA RESPIMAT $146 6 payments
  10. STIOLTO RESPIMAT $126 5 payments
  11. Other $1,331 72 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 7 billing codes

Paid by Medicare

$20,131

Medicare's payments for the services billed

Medicare patients

145

Average age 79

Services billed

291

90 women, 55 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 68%
Ischemic heart disease 52%
Atrial fibrillation 50%
Heart failure 46%
Chronic kidney disease 46%
Diabetes 44%
Depression 42%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

182 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record